Errata by unknown
Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums
G, Osicka TM. Reduction of the accumulation of advanced glycation end products by ACE inhibition in
experimental diabetic nephropathy. Diabetes 2002;51:3274–3282
As printed, the name of an author, Louise A. Burrell, is incorrect. The correct name of the author is Louise M. Burrell.
The online version reﬂects these changes.
Oudit GY, Liu GC, Zhong J, Basu R, Chow FL, Zhou J, Loibner H, Janzek E, Schuster M, Penninger JM,
Herzenberg AM, Kassiri Z, Scholey JW. Human recombinant ACE2 reduces the progression of diabetic
nephropathy. Diabetes 2010;59:529–538
In the print version of the article listed above, the third and fourth labels on the top of Figure 2 and the third and fourth
labels on the top and bottom of Figure 3 are incorrect. The correct ﬁgures appear below. The online version reﬂects
these changes.
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FIG. 2. Glomerular mesangial expansion and thickening of basement membrane were reduced by treatment with human recombinant ACE2. A–C:
Representative light micrographs of periodic acid Schiff–stained kidney sections from each group of mice (magniﬁcation 630) (A) with
quantiﬁcation of the glomerular volume (C) showing glomerular expansion in the diabetic Akita mice and a marked reduction in response to
hrACE2. B and D: Transmission electron microscopy of the glomeruli (B) with quantiﬁcation of the glomerular basement thickness (D) showing
increased glomerular basement membrane thickness in the Akita Ins2
WT/C96Y mice, which was normalized by treatment with hrACE2. White
arrows indicate the glomerular basement membrane. E: Mesangial matrix expansion score showing increased mesangial expansion in diabetic
Akita kidneys, which was prevented by hrACE2. n  5 for all groups. *P < 0.05 compared with all other groups and #P < 0.05 compared with
placebo  Ins2
WT/WT group using ANOVA with multiple comparison testing. (A high-quality digital representation of this ﬁgure is available in the
online issue.)
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FIG. 3. Increased glomerular expression of -SMA and collagen III in the diabetic Akita kidneys without evidence of inﬂammatory changes in
response to human recombinant ACE2. A–D: Increased glomerular immunostaining for -SMA (A) and collagen III (B) in diabetic Akita mice that
was quantiﬁed based on computer image analysis scores of glomerular immunostaining of -SMA (C) and collagen III (D). Positive controls are
shown as staining in renal blood vessels for -SMA and from a kidney after 14 days of ureteral obstruction for collagen III. n  5 for all groups.
*P < 0.01 compared with all other groups using ANOVA and multiple comparison testing. E and F: Immunohistochemical-speciﬁc staining of
neutrophil and macrophage revealed no evidence of inﬂammation in the diabetic Akita mice without a differential impact with treatment with
hrACE2. Positive controls were taken from mouse spleen and lung tissue. Scale bar, 100 m. (A high-quality digital representation of this ﬁgure
is available in the online issue.)
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